HFSAX Performance — Hundredfold Select Alternative Fund, Investor Class
Data updated: 2026-10-09
HFSAX returned +1.99% year to date and +11.02% over one year to May 2026. Annualised returns are +9.81% over 3 years and +3.43% over 5 years. The fund trailed its Moderate Allocation category average: $100 invested three years ago grew to $132, against $144 for the category, and to $111 over one year, against $119. Volatility over the past three years was 6.32% a year. In the 12 months to May 2026 the fund lost a net $9.8M, and assets reached $132.50M.
HFSAX Growth of $100
What $100 invested in Hundredfold Select Alternative Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Moderate Allocation category average over the same months.
| Period | HFSAX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $111 | $119 |
| 3 years (Jun 2023 – May 2026) | $132 | $144 |
| 5 years (Jun 2021 – May 2026) | $118 | $135 |
| Since data start (Mar 2020 – May 2026) | $173 | $167 |
HFSAX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.99% |
| 1 year | +11.02% |
| 3 years (annualised) | +9.81% |
| 5 years (annualised) | +3.43% |
HFSAX Annual Returns
Calendar-year total returns of Hundredfold Select Alternative Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +1.99% |
| 2025 | +11.99% |
| 2024 | +3.30% |
| 2023 | +11.39% |
| 2022 | −9.42% |
| 2021 | +9.05% |
| 2020 (Mar–Dec) | +33.11% |
HFSAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.1% | +1.5% | −3.4% | +1.7% | +1.1% | — | — | — | — | — | — | — |
| 2025 | +0.5% | +1.0% | −0.8% | +0.4% | +1.8% | +2.4% | −0.5% | +1.6% | +1.9% | +1.2% | +0.4% | +1.6% |
| 2024 | −1.6% | +1.0% | +1.5% | −2.4% | −0.2% | +1.4% | +2.1% | +0.1% | +2.5% | −1.7% | +2.3% | −1.7% |
| 2023 | +4.2% | −3.4% | −0.5% | −1.0% | 0.0% | +0.9% | +2.8% | −1.1% | −1.1% | +0.2% | +4.4% | +5.7% |
| 2022 | +0.1% | −0.2% | 0.0% | −3.2% | −1.8% | −1.6% | +2.1% | −2.9% | −1.2% | −0.9% | +1.7% | −1.9% |
| 2021 | +0.7% | +3.1% | 0.0% | +3.9% | +1.6% | +0.6% | −2.5% | +0.6% | −1.0% | +1.4% | −0.1% | +0.4% |
| 2020 | — | — | +0.4% | +2.5% | +3.4% | +2.6% | +5.4% | +4.3% | −2.2% | +2.3% | +6.2% | +4.4% |
HFSAX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 6.32%
- 3-year Sharpe ratio: 0.84 (vs 4.5% risk-free rate)
- Best month: +5.72% (Dec 2023)
- Worst month: −3.36% (Mar 2026)
HFSAX Fund Flows
Monthly money in and out of Hundredfold Select Alternative Fund, from SEC Form N-PORT.
- 12-month net flow: −$9.8M
- 12-month gross sales (incl. reinvestments): $39.9M
- Sales ÷ redemptions: 0.80×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $2.0M | $3.0M | −$961K |
| Apr 2026 | $1.6M | $1.8M | −$259K |
| Mar 2026 | $2.4M | $3.2M | −$843K |
| Feb 2026 | $1.9M | $2.2M | −$276K |
| Jan 2026 | $1.9M | $12.8M | −$10.9M |
| Dec 2025 | $14.4M | $3.3M | $11.1M |
| Nov 2025 | $2.0M | $5.7M | −$3.7M |
| Oct 2025 | $5.0M | $3.0M | $2.0M |
| Sep 2025 | $1.4M | $3.7M | −$2.3M |
| Aug 2025 | $4.4M | $4.9M | −$447K |
| Jul 2025 | $2.2M | $3.4M | −$1.2M |
| Jun 2025 | $843K | $2.9M | −$2.0M |
HFSAX Assets Under Management
Net assets of Hundredfold Select Alternative Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-08-31 | $132.50M |
| 2026-05-31 | $110.04M |
| 2026-02-28 | $140.63M |
| 2025-11-30 | $145.12M |
| 2025-08-31 | $147.31M |
| 2025-05-31 | $124.25M |
| 2025-02-28 | $143.16M |
| 2024-11-30 | $153.21M |
| 2024-08-31 | $151.81M |
| 2024-05-31 | $159.22M |
| 2024-02-29 | $177.52M |
| 2023-11-30 | $176.52M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.